Arlt A - Search Results

1

The expression of the beta-defensins hBD-2 and hBD-3 is differentially regulated by NF-kappaB and MAPK/AP-1 pathways in an in vitro model of Candida esophagitis.

Steubesand N, Kiehne K, Brunke G, Pahl R, Reiss K, Herzig KH, Schubert S, Schreiber S, Fölsch UR, Rosenstiel P, Arlt A. Steubesand N, et al. Among authors: arlt a. BMC Immunol. 2009 Jun 12;10:36. doi: 10.1186/1471-2172-10-36. BMC Immunol. 2009. PMID: 19523197 Free PMC article.

2

Expression of the NF-kappa B target gene IEX-1 (p22/PRG1) does not prevent cell death but instead triggers apoptosis in Hela cells.

Arlt A, Grobe O, Sieke A, Kruse ML, Fölsch UR, Schmidt WE, Schäfer H. Arlt A, et al. Oncogene. 2001 Jan 4;20(1):69-76. doi: 10.1038/sj.onc.1204061. Oncogene. 2001. PMID: 11244505

3

Functional disruption of IEX-1 expression by concatemeric hammerhead ribozymes alters growth properties of 293 cells.

Grobe O, Arlt A, Ungefroren H, Krupp G, Fölsch UR, Schmidt WE, Schäfer H. Grobe O, et al. Among authors: arlt a. FEBS Lett. 2001 Apr 13;494(3):196-200. doi: 10.1016/s0014-5793(01)02344-4. FEBS Lett. 2001. PMID: 11311240 Free article.

4

Inhibition of NF-kappaB sensitizes human pancreatic carcinoma cells to apoptosis induced by etoposide (VP16) or doxorubicin.

Arlt A, Vorndamm J, Breitenbroich M, Fölsch UR, Kalthoff H, Schmidt WE, Schäfer H. Arlt A, et al. Oncogene. 2001 Feb 15;20(7):859-68. doi: 10.1038/sj.onc.1204168. Oncogene. 2001. PMID: 11314019

5

Autocrine production of interleukin 1beta confers constitutive nuclear factor kappaB activity and chemoresistance in pancreatic carcinoma cell lines.

Arlt A, Vorndamm J, Müerköster S, Yu H, Schmidt WE, Fölsch UR, Schäfer H. Arlt A, et al. Cancer Res. 2002 Feb 1;62(3):910-6. Cancer Res. 2002. PMID: 11830551

6

Angiotensin AT2 receptor ligands: do they have potential as future treatments for neurological disease?

Rosenstiel P, Gallinat S, Arlt A, Unger T, Sievers J, Lucius R. Rosenstiel P, et al. Among authors: arlt a. CNS Drugs. 2002;16(3):145-53. doi: 10.2165/00023210-200216030-00001. CNS Drugs. 2002. PMID: 11888335 Review.

7

Usage of the NF-kappaB inhibitor sulfasalazine as sensitizing agent in combined chemotherapy of pancreatic cancer.

Müerköster S, Arlt A, Witt M, Gehrz A, Haye S, March C, Grohmann F, Wegehenkel K, Kalthoff H, Fölsch UR, Schäfer H. Müerköster S, et al. Among authors: arlt a. Int J Cancer. 2003 Apr 20;104(4):469-76. doi: 10.1002/ijc.10963. Int J Cancer. 2003. PMID: 12584745

8

Role of NF-kappaB and Akt/PI3K in the resistance of pancreatic carcinoma cell lines against gemcitabine-induced cell death.

Arlt A, Gehrz A, Müerköster S, Vorndamm J, Kruse ML, Fölsch UR, Schäfer H. Arlt A, et al. Oncogene. 2003 May 22;22(21):3243-51. doi: 10.1038/sj.onc.1206390. Oncogene. 2003. PMID: 12761494

9

The early response gene IEX-1 attenuates NF-kappaB activation in 293 cells, a possible counter-regulatory process leading to enhanced cell death.

Arlt A, Kruse ML, Breitenbroich M, Gehrz A, Koc B, Minkenberg J, Fölsch UR, Schäfer H. Arlt A, et al. Oncogene. 2003 May 22;22(21):3343-51. doi: 10.1038/sj.onc.1206524. Oncogene. 2003. PMID: 12761504

10

Tumor stroma interactions induce chemoresistance in pancreatic ductal carcinoma cells involving increased secretion and paracrine effects of nitric oxide and interleukin-1beta.

Müerköster S, Wegehenkel K, Arlt A, Witt M, Sipos B, Kruse ML, Sebens T, Klöppel G, Kalthoff H, Fölsch UR, Schäfer H. Müerköster S, et al. Among authors: arlt a. Cancer Res. 2004 Feb 15;64(4):1331-7. doi: 10.1158/0008-5472.can-03-1860. Cancer Res. 2004. PMID: 14973050

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

186 results

Search Page

Filters